國立虎尾科技大學 |

Multiple Myeloma and Other Plasma Cell Neoplasms

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Multiple Myeloma and Other Plasma Cell Neoplasms/ edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
其他作者:	Dimopoulos, Meletios A.
面頁冊數:	VI, 245 p. 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-319-25586-6
ISBN:	9783319255866

Multiple Myeloma and Other Plasma Cell Neoplasms
Multiple Myeloma and Other Plasma Cell Neoplasms[electronic resource] /edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos. - 1st ed. 2018. - VI, 245 p. 14 illus. in color.online resource. - Hematologic Malignancies,2197-9766. - Hematologic Malignancies,.

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. .

ISBN: 9783319255866

Standard No.: 10.1007/978-3-319-25586-6doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Multiple Myeloma and Other Plasma Cell Neoplasms
LDR:02509nam a22003975i 4500 001 995852
003 DE-He213
005 20200705061603.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319255866 $9 978-3-319-25586-6
024 7 $a 10.1007/978-3-319-25586-6 $2 doi
035 $a 978-3-319-25586-6
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Multiple Myeloma and Other Plasma Cell Neoplasms $h [electronic resource] / $c edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VI, 245 p. 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Hematologic Malignancies, $x 2197-9766
520 $a This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. .
650 0 $a Hematology. $3 645254
650 0 $a Oncology . $3 1253469
650 0 $a Immunology. $3 592892
650 2 4 $a Oncology. $3 593951
700 1 $a Dimopoulos, Meletios A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1286945
700 1 $a Facon, Thierry. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1286946
700 1 $a Terpos, Evangelos. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1286947
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319255842
776 0 8 $i Printed edition: $z 9783319255859
776 0 8 $i Printed edition: $z 9783030132422
830 0 $a Hematologic Malignancies, $x 2197-9766 $3 1253495
856 4 0 $u https://doi.org/10.1007/978-3-319-25586-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)